Company Continues to Expand in Overseas Markets DELRAY BEACH, Fla.--(BUSINESS WIRE)--September 26, 2007--
VeriChip Corporation (NASDAQ:CHIP), a provider of RFID systems for healthcare and patient-related needs, announced today that its wholly owned subsidiary, Xmark Corporation, has made its first sale in Switzerland.
Xmark's ProtecPoint wander prevention system is being installed at Stiftung Schloss Turbenthal, a center for the deaf and elderly in Gehorlosendorf, near Zurich. The system is to be installed by Xmark's dealer Avatech AG. The ProtecPoint system provides cost-effective protection for wander-prone individuals, and is part of Xmark's suite of RFID solutions to locate and protect people in indoor environments.
"Xmark continues to expand in overseas markets, building on our industry leading position in North America," said Daniel A. Gunther, President and CEO of Xmark. "We look forward to working with Avatech on future opportunities in Switzerland."
Mr. Martin Naef, manager of logistics and facilities at Stiftung Schloss Turbenthal, said, "We choose Avatech AG and the ProtecPoint solution because of the easy installation and administration. ProtecPoint provides effective support for the nursing staff. We have been able to reduce manually monitoring of wandering residents."
For more information on Xmark's products, please contact 1-866-55-XMARK or email email@example.com. Additional information can be found online at www.xmark.com.
Based in Ottawa, Ontario, Xmark is a wholly owned subsidiary of VeriChip Corporation. For over 25 years, Xmark Corporation has provided Radio Frequency Identification (RFID) solutions to identify, locate, and protect people and assets in healthcare environments. Its market-leading infant protection, wander prevention, personal duress, and asset tracking applications are trusted by over 5,000 healthcare institutions worldwide to keep individuals safe.
Xmark products are installed and serviced through an international network of authorized dealers, backed by a dedicated technical services department at Xmark. All aspects of Xmark's business are certified to the ISO 9001 quality standard.
VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. In addition, VeriChip recently began marketing its VeriMed(TM) Patient Identification System, a passive RFID system for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration.
VeriChip Corporation is majority-owned by Applied Digital Solutions Inc. (Nasdaq:ADSX), which also owns a majority position in Digital Angel Corporation (AMEX:DOC). For more information on VeriChip, please call 1-800-970-2447, or email firstname.lastname@example.org. Additional information can be found online at http://www.verichipcorp.com.
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.
CONTACT: For VeriChip Corporation, Delray Beach CEOcast
Dan Schustack, 212-732-4300
Allison Tomek, 561-805-8008
SOURCE: VeriChip Corporation Copyright Business Wire 2007